Eric J. Devor

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.1Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Genomic characterization of five commonly used endometrial cancer cell lines

International Journal of Oncology(2020)10.3892/ijo.2020.5139

Top 18%

1.1DataRank

Top 18%43 citations

Jesús González Bosquet, Kristina W. Thiel, Kimberly K. Leslie, Eric J. Devor

Papers

Driven by 25 papers — median percentile 82. Top paper: “Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study”.

Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.01.025

N/A

2.5DataRank · unranked

85 citations

Virginia L. Filiaci, Adrianne Mallen, Kristina W. Thiel, Eric J. Devor, Katherine Moxley +17 more

Genomic characterization of five commonly used endometrial cancer cell lines

International Journal of Oncology(2020)10.3892/ijo.2020.5139

Top 18%

1.1DataRank

Top 18%43 citations

Jesús González Bosquet, Kristina W. Thiel, Kimberly K. Leslie, Eric J. Devor

Creation and validation of models to predict response to primary treatment in serous ovarian cancer

Scientific Reports(2021)10.1038/s41598-021-85256-9

N/A

0.515DataRank · unranked

30 citations

Eric J. Devor, A.M. Newtson, Brian J. Smith, David Bender, Michael J. Goodheart +5 more

Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer

Cell Death and Disease(2022)10.1038/s41419-022-04508-2

N/A

0.494DataRank · unranked

26 citations

Yuping Zhang, Paige K. Malmrose, Haley A. Losh, A.M. Newtson, Eric J. Devor +3 more

FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways

Clinical and Translational Medicine(2023)10.1002/ctm2.1223

N/A

0.477DataRank · unranked

23 citations

Jesús González Bosquet, Joseph Skurski, Eric J. Devor, Erin B. Dickerson, Warren B. Nothnick +4 more

Bacterial, Archaea, and Viral Transcripts (BAVT) Expression in Gynecological Cancers and Correlation with Regulatory Regions of the Genome

Cancers(2021)10.3390/cancers13051109

N/A

0.425DataRank · unranked

16 citations

Silvana Pedra-Nobre, Eric J. Devor, Kristina W. Thiel, Michael J. Goodheart, David Bender +2 more

Identification of Novel lncRNAs in Ovarian Cancer and Their Impact on Overall Survival

International Journal of Molecular Sciences(2021)10.3390/ijms22031079

N/A

0.345DataRank · unranked

9 citations

Douglas Russo, A.M. Newtson, Henry Reyes Pineda, Yasmin Lyons, Eric J. Devor +4 more

The Synthetic Curcumin Analog HO-3867 Rescues Suppression of PLAC1 Expression in Ovarian Cancer Cells

Pharmaceuticals(2021)10.3390/ph14090942

N/A

0.345DataRank · unranked

9 citations

Brandon Schickling, Jace R. Lapierre, David Bender, Jesús González Bosquet, Kimberly K. Leslie +1 more

Effects of maternal hypertension on cord blood Arginine vasopressin receptor expression

Pregnancy Hypertension(2022)10.1016/j.preghy.2022.11.005

N/A

0.208DataRank · unranked

3 citations

Lauren Evoy Davis, Brandon Schickling, Eric J. Devor, Lydia Von Tersch, Mark K. Santillan +2 more

Global expression analysis of endometrial cancer cells in response to progesterone identifies new therapeutic targets

The Journal of Steroid Biochemistry and Molecular Biology(2023)10.1016/j.jsbmb.2023.106399

N/A

0.165DataRank · unranked

2 citations

A.M. Newtson, Eric J. Devor, Yuping Zhang, Paige K. Malmrose, Jianling Bi +13 more

Particles and Prejudice: Nanomedicine Approaches to Reducing Health Disparities in Endometrial Cancer

Small(2023)10.1002/smll.202300096

N/A

0DataRank · unranked

9 citations

Abigail M. Folberg, Zachary K. Beickman, Eric J. Devor, Kimberly K. Leslie, Brittany E. Givens +1 more

Microbial Communities in Gynecological Cancers and Their Association with Tumor Somatic Variation

Cancers(2023)10.3390/cancers15133316

N/A

0DataRank · unranked

3 citations

Megan McDonald, David Bender, Bruce A. Smith, Kimberly K. Leslie, Michael J. Goodheart +2 more

Anti-angiogenic mechanisms and serotonergic dysfunction in the Rgs2 knockout model for the study of psycho-obstetric risk

Neuropsychopharmacology(2023)10.1038/s41386-023-01749-3

N/A

0DataRank · unranked

4 citations

Michaela Kiel, Aleigha Gugel, Brandon Schickling, Kaylee R. Weaver, Marisol Lauffer +10 more

BRCA2 Status Alters the Effect of the P53 Reactivator HO-3867 in Ovarian Cancer Cells

Journal of Cancer Science and Clinical Therapeutics(2023)10.26502/jcsct.5079197

N/A

0DataRank · unranked

0 citations

Ariane E Thomas, Brandon Schickling, Eric J. Devor

Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer

Cancers(2025)10.3390/cancers17040598

N/A

0DataRank · unranked

14 citations

Ian S. Hagemann, David G. Mutch, Eric J. Devor, Paige K. Malmrose, Yuping Zhang +4 more

Novel p53 reactivators that are synergistic with olaparib for the treatment of gynecologic cancers with mutant p53

Translational Oncology(2025)10.1016/j.tranon.2025.102522

N/A

0DataRank · unranked

6 citations

Jamie L. Padilla, Angelina Licor, Mara P. Steinkamp, Irina V. Lagutina, Yan Guo +8 more

Detargeting Lentiviral-Mediated CFTR Expression in Airway Basal Cells Using miR-106b

Genes(2020)10.3390/genes11101169

N/A

0DataRank · unranked

7 citations

Rosie E. Reeves, Guillermo S. Romano Ibarra, Thomas J. Lynch, Weam Shahin, Zehua Feng +11 more

ES-2 Ovarian Cancer Cells Present a Genomic Profile Inconsistent with their Reported History

Research Square(2020)10.21203/rs.3.rs-28022/v1

N/A

0DataRank · unranked

1 citations

Jace R. Lapierre, Kimberly K. Leslie, David Bender, Eric J. Devor

Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing

Cancers(2021)10.3390/cancers13122901

N/A

0DataRank · unranked

68 citations

A.M. Newtson, Yuping Zhang, Eric J. Devor, Megan I. Samuelson, Kristina W. Thiel +2 more

Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy

Pharmaceuticals(2021)10.3390/ph14070682

N/A

0DataRank · unranked

15 citations

Garima Dixit, Yuping Zhang, Eric J. Devor, Haley A. Losh, A.M. Newtson +6 more

Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer

International Journal of Molecular Sciences(2021)10.3390/ijms22094791

N/A

0DataRank · unranked

12 citations

Henry Reyes Pineda, Eric J. Devor, Michael J. Goodheart, Jesús González Bosquet, A.M. Newtson

A nuclear polymorphism at the 8q24 region is associated with improved survival time and chemo‑response in high‑grade serous ovarian cancer

Oncology Letters(2021)10.3892/ol.2021.12994

N/A

0DataRank · unranked

8 citations

Nicholas Cardillo, Eric J. Devor, Jesús González Bosquet, Danielle Ikoma

Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib Over Bevacizumab: Cell Cycle Abrogation and Synergy With Chemotherapy

Research Square(2021)10.21203/rs.3.rs-179830/v1

N/A

0DataRank · unranked

1 citations

Garima Dixit, Yuping Zhang, Eric J. Devor, Haley A. Losh, A.M. Newtson +6 more

Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer

Cancers(2022)10.3390/cancers14143554

N/A

0DataRank · unranked

5 citations

Eric J. Devor, Silvana Pedra Nobre, A.M. Newtson, Kimberly K. Leslie, David Bender +4 more

Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High Grade Serous Ovarian Cancer

Research Square(2022)10.21203/rs.3.rs-1167716/v1

N/A

0DataRank · unranked

3 citations

Eric J. Devor, Silvana Pedra Nobre, A.M. Newtson, Kimberly K. Leslie, David Bender +4 more

Eric J. Devor

Indexed papers

Top data-sharing exemplar

Papers